| |
1 2 3 4 5 6 7 8 9 10
читать далее ... and basophils. Trends Pharmacol. Sci., 1983, v. 4, P. 432-437. 15. Wedi В., Novacovic V., Koerner M., Kapp A. Chronic urticaria serum induces nistamine release, leukotriene production and basophil CD63 surface expression - inhibitory effects of anti-inflammatory drugs. J.AIIergy Clin. Immunol., 2000, v 105, P. 552-560. 16. Woosly R.L, Chen Y., Freiman J.P., Gillis R.A. Mechanism of the cardiotoxic actions of terfenadine. JAMA, 1993, 269, P. 1532-36. 17. Nightingale S.L. Warnings issued on nonsedating antihistamlnes terfenadine and astemizole. JAMA, 1992, 266, P.705. 18. Аллергия, астма и клиническая иммунология, 1998, № 9, с. 10-32. 19. Izquierdo /., Merlos M., Garcia-Rafanell J. A new selective histamme H1 receptor and platelet-activating factor (PAF) antagonist. Drugs of Today, 2003, 39(6), P.451-68. 20. Almqvist С., Pershagen G; Wickman C.M. Socioeconomic status and risck of asthma and sensitisation at four years in a birth cohort. Abstract book of XXIII EAACI Congress, 12-16 June 2004, Amsterdam, Editors: Roy Gerth van WijKatal., N. 961. 21. РПС. Энциклопедия лекарств, 2004, 000 "РЛС-2004". 22. Manual of allergy and immunology. Fourth edition. Edited by Adelman D.C., Casale Th.B., Corren J. Lippincott Williams &Wilkins, USA, 2002, P. 122. 23. MygindN. Glucocorticosteroids and rhinitis. Allergy, 1993, 48, P.476-90. 24. Soderberg -Warner M.L. Nasal septal perforation associated with topical corticosteroid therapy. J.Pediatr., 1984, 105, P.840-1. 25. Reynolds N.A., Scott L Ciclesonide. Drugs, 2004, 64(5), P.511-19.Источник: Маркова Т.П. Русский медицинский журнал. 2006. Т.14. №7. С.548-553
1 2 3 4 5 6 7 8 9 10
|
| | |
|
